Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03140423 · ClinicalTrials.gov registry record · Phase 4
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
A Phase 4 study, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- Phase 4
- Development phase
- 353,323
- Enrollment target
NCT03140423 is a Phase 4 study that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 353,323 participants.
The verdict
NCT03140423, a Phase 4 study, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 353,323 participants
- Enrollment target
Study Summary
The Swap Out Trial is a cluster randomized controlled trial of HCA hospitals, evaluating the non-inferiority of two decolonization regimens: Arm 1 Routine Care: ICU nasal decolonization with mupirocin twice daily for 5 days in the context of chlorhexidine for daily bathing; Arm 2 Intervention: ICU nasal decolonization with iodophor twice daily for 5 days in the context of chlorhexidine for daily bathing Note: that enrolled "subjects" represents 137 individual HCA Hospitals (representing \~235 ICUs) that have been randomized.
Interventions
- DRUG Arm 1. Routine Care (Mupirocin/CHG)
- DRUG Arm 2. Iodophor/CHG Decolonization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353,323 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2023-11-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03140423
The ClinicalTrials.gov registry entry for NCT03140423 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 353,323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arm 1. Routine Care (Mupirocin/CHG) is the first listed.
NCT03140423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03140423 about?
NCT03140423 is a clinical study titled "Mupirocin-Iodophor ICU Decolonization Swap Out Trial". The Swap Out Trial is a cluster randomized controlled trial of HCA hospitals, evaluating the non-inferiority of two decolonization regimens: Arm 1 Routine Care: ICU nasal decolonization with mupirocin twice daily for 5 days in the context of chlorhexidine for daily bathing; Arm 2 Intervention: ICU ...
What is the current status of trial NCT03140423?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 353,323 participants. The study started on 2017-05-01. Estimated completion is 2023-11-06.
What interventions are being tested in trial NCT03140423?
The interventions under investigation include: Arm 1. Routine Care (Mupirocin/CHG) (DRUG), Arm 2. Iodophor/CHG Decolonization (DRUG).
Who is sponsoring clinical trial NCT03140423?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.